Articles by Michael E. Chernew, PhD
Dr Cliff Goodman leads a discussion featuring panelists including The American Journal of Managed Care's co-editor-in-chief, Dr Michael Chernew. Topics of the discussion include the impact of value-based pricing in the market, and how different pricing models such as bundled payments or accountable care organizations impact risk factors.
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
ByDouglas K. Owens, MD,Wade Aubry, MD,Roy Beck, MD,Joshua Benner, MD,Jan E. Berger, PharmD,Michael E. Chernew, PhD,Felicia Forma, BSc,Dana P. Goldman, PhD,William H. Herman, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Anne L Peters, MD Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Competitive bidding characterizes market-based proposals to control Medicare spending, but in this first empirical study of bidding in Medicare, we find that competition is lacking.
Recognizing shared features of 2 Medicare payment reform strategies, premium support and global payment, may help us focus on, and resolve, the differences.
Bending the Curve Through Health Reform Implementation
ByJoseph Antos, PhD,John Bertko,Michael E. Chernew, PhD,David Cutler, PhD,Francois de Brantes,Dana Goldman, PhD,Bob Kocher, MD,Mark McClellan, MD, PhD,Elizabeth McGlynn, PhD,Mark Pauly, PhD,Leonard Schaeffer,Stephen Shortell, PhD Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Traditional Medicare and the large-firm commercial sector have a positive correlation in hospital utilization, but a lack of correlation in spending.
Bending the Curve: Effective Steps to Address Long-Term Healthcare Spending Growth
ByJoseph Antos, PhD,John Bertko,Michael E. Chernew, PhD,David Cutler, PhD,Dana Goldman, PhD,Mark McClellan, MD, PhD,Elizabeth McGlynn, PhD,Mark Pauly, PhD,Leonard Schaeffer,Stephen Shortell, PhD A group of experts who have spent their careers studying the healthcare system have convened to identify a path for sustainable reform in healthcare cost growth.
In this commentary, our Co-Editors-in-Chief advocate valuebased principles that align incentives to encourage use of high value services as an important tool in healthcare reform.
Value-based insurance design may reduce the adverse consequences of cost sharing, as well as support quality improvement initiatives.
Univariate Solutions in a Multivariate World: Can We Afford to Practice as in the "good old days"?
ByLaurence F. McMahon Jr, MD, MPH,Rodney Hayward, MD,Sanjay Saint, MD, MPH,Michael E. Chernew, PhD,A. Mark Fendrick, MD Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients with Influenza-Like Illness: What a Difference a Day Makes
BySusan G. Blitz, MD, MPH,Peter Cram, MD,Michael E. Chernew, PhD,Arnold S. Monto, MD,A. Mark Fendrick, MD Correspondence regarding, "Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model"
ByBernard S. Bloom, PhD,Michael E. Chernew, PhD,Richard Hirth, PhD,A. Mark Fendrick, MD,Reply by Robert J. Rubin, MD,Elisa F. Cascade, MBA,David A. Peura, MD,C. Mel Wilcox, MD,Daniel N.